Profile
From 2000 to 2002, An Song worked at Stanford University as a Research Assistant Professor.
From 2002 to 2018, worked at Genentech, Inc., including the role of Senior Director-BioAnalytical Sciences from 2016 to 2018.
From 2018 to 2021, worked at Immune-Onc Therapeutics, Inc. as Chief Scientific Officer from 2019 to 2021.
From 2021 to 2024, worked at 4D Molecular Therapeutics, Inc. as Chief Development Officer.
Education includes a doctorate from Indiana University.
Former positions of An Song
| Companies | Position | End |
|---|---|---|
Immune-Onc Therapeutics, Inc.
Immune-Onc Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company advancing novel therapies that target myeloid cells | Chief Tech/Sci/R&D Officer | 01/09/2021 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/07/2018 |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/08/2002 |
| 4D MOLECULAR THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of An Song
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indiana University
Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
4D Molecular Therapeutics, Inc.
4D Molecular Therapeutics, Inc. BiotechnologyHealth Technology Designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions | Health Technology |
Immune-Onc Therapeutics, Inc.
Immune-Onc Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company advancing novel therapies that target myeloid cells | Health Technology |
- Stock Market
- Insiders
- An Song
















